Your browser doesn't support javascript.
loading
Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance.
Davis, John W; Ward, John F; Pettaway, Curtis A; Wang, Xuemei; Kuban, Deborah; Frank, Steven J; Lee, Andrew K; Pisters, Louis L; Matin, Surena F; Shah, Jay B; Karam, Jose A; Chapin, Brian F; Papadopoulos, John N; Achim, Mary; Hoffman, Karen E; Pugh, Thomas J; Choi, Seungtaek; Troncoso, Patricia; Logothetis, Christopher J; Kim, Jeri.
Affiliation
  • Davis JW; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ward JF; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pettaway CA; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang X; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kuban D; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Frank SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lee AK; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pisters LL; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Matin SF; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shah JB; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Karam JA; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chapin BF; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Papadopoulos JN; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Achim M; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hoffman KE; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pugh TJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Choi S; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Troncoso P; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Logothetis CJ; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kim J; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
BJU Int ; 118(1): 68-76, 2016 07.
Article in En | MEDLINE | ID: mdl-26059275
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Watchful Waiting Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2016 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Watchful Waiting Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2016 Type: Article Affiliation country: United States